Robin Fåhræus
- Molecular Biology top 2%
- Oncology top 0.5%
- Immunology top 2%
- Pathology and Forensic Medicine top 2%
- Cancer Research top 5%
- Co-authors
- Yili YinBénédicte ManouryChrysoula DaskalogianniVanesa Olivares‐IllanaDavid P. LaneLars RymoMarco M. CandeiasSébastien Apcher
- Topics
- Cancer-related Molecular Pathways (45 papers)RNA modifications and cancer (26 papers)Ubiquitin and proteasome pathways (24 papers)
- Cited by
- OncologyImmunologyMolecular Biology
In The Last Decade
Robin Fåhræus
131 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 3.1k
- Oncology 2.9k
- Immunology 1.0k
- Pathology and Forensic Medicine 745
- Cancer Research 632
Countries citing papers authored by Robin Fåhræus
This map shows the geographic impact of Robin Fåhræus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Fåhræus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Fåhræus more than expected).
Fields of papers citing papers by Robin Fåhræus
This network shows the impact of papers produced by Robin Fåhræus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Fåhræus. The network helps show where Robin Fåhræus may publish in the future.
Co-authorship network of co-authors of Robin Fåhræus
This figure shows the co-authorship network connecting the top 25 collaborators of Robin Fåhræus. A scholar is included among the top collaborators of Robin Fåhræus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Fåhræus. Robin Fåhræus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 23 | |
| 6 | 6 | |
| 7 | 9 | |
| 8 | 234 | |
| 9 | 45 | |
| 10 | 19 | |
| 11 | 78 | |
| 12 | 23 | |
| 13 | 48 | |
| 14 | 144 | |
| 15 | 48 | |
| 16 | 45 | |
| 17 | 73 | |
| 18 | 19 | |
| 19 | 127 | |
| 20 | 4 |
About Robin Fåhræus
Robin Fåhræus is a scholar working on Oncology, Biotechnology and Immunology, having authored 136 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (45 papers), RNA modifications and cancer (26 papers) and Ubiquitin and proteasome pathways (24 papers). The work is most often cited by research in Oncology (2.9k citations), Immunology (1.0k citations) and Molecular Biology (3.1k citations). Robin Fåhræus has collaborated with scholars based in France, Sweden and Czechia. Frequent co-authors include Yili Yin, Bénédicte Manoury, Chrysoula Daskalogianni, Vanesa Olivares‐Illana, David P. Lane, Lars Rymo, Marco M. Candeias, Sébastien Apcher, George Klein and Laurence Malbert-Colas. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.